KLRA Kailera Therapeutics, Inc.
Nasdaq · SEC CIK 2096997 · EDGAR
- Bought, last 12 months
- $326.75M 5 purchases by 5 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 20 since 2026-04-20, latest 2026-09-09 19:29
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kaplan Andrew T. | Dir, 10% | $134.38M | — |
| BAIN CAPITAL INVESTORS LLC | 10% | $134.38M | — |
| Bain Capital Life Sciences Investors, LLC | 10% | $25.00M | — |
| Koppel Adam | Dir, 10% | $25.00M | — |
| RTW INVESTMENTS, LP | 10% | $8.00M | — |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% | — | — |
| Renaud Ronald C JR | CEO, Pres, Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-11 16:05 | 2026-06-09 | KLRA | Renaud Ronald C JR | CEO, Pres, Dir | M - OptEx | $5.25 | +38.1K | 38.1K | New | +$200.0K |
| DI | 2026-04-22 16:15 | 2026-04-20 | KLRA | RTW INVESTMENTS, LP | 10% | C - Cnv Deriv | — | +10.28M | 10.28M | New | — |
| DI | 2026-04-22 16:15 | 2026-04-20 | KLRA | RTW INVESTMENTS, LP | 10% | P - Purchase | $16.00 | +500.0K | 10.78M | +5% | +$8.00M |
| DM | 2026-04-22 06:03 | 2026-04-20 | KLRA | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% | C - Cnv Deriv | — | +11.51M | 2.03M | New | — |
| DI | 2026-04-20 18:10 | 2026-04-20 | KLRA | BAIN CAPITAL INVESTORS LLC | 10% | C - Cnv Deriv | — | +17.86M | 17.86M | New | — |
| DI | 2026-04-20 18:10 | 2026-04-20 | KLRA | BAIN CAPITAL INVESTORS LLC | 10% | P - Purchase | $16.00 | +8.40M | 26.26M | +47% | +$134.38M |
| DMI | 2026-04-20 18:08 | 2026-04-20 | KLRA | Koppel Adam | Dir, 10% | C - Cnv Deriv | — | +21.02M | 21.02M | New | — |
| DI | 2026-04-20 18:08 | 2026-04-20 | KLRA | Koppel Adam | Dir, 10% | P - Purchase | $16.00 | +1.56M | 22.58M | +7% | +$25.00M |
| DMI | 2026-04-20 18:01 | 2026-04-20 | KLRA | Bain Capital Life Sciences Investors, LLC | 10% | C - Cnv Deriv | — | +21.02M | 21.02M | New | — |
| DI | 2026-04-20 18:01 | 2026-04-20 | KLRA | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $16.00 | +1.56M | 22.58M | +7% | +$25.00M |
| DI | 2026-04-20 18:00 | 2026-04-20 | KLRA | Kaplan Andrew T. | Dir, 10% | C - Cnv Deriv | — | +17.86M | 17.86M | New | — |
| DI | 2026-04-20 18:00 | 2026-04-20 | KLRA | Kaplan Andrew T. | Dir, 10% | P - Purchase | $16.00 | +8.40M | 26.26M | +47% | +$134.38M |
Purchase Sale Sale after option exercise All abbreviations